41 results on '"Buxeda, Anna"'
Search Results
2. Dynamics of HLA and angiotensin II type 1 receptor antibodies during pregnancy
- Author
-
Burballa, Carla, Llinàs-Mallol, Laura, Vázquez, Susana, Pérez-Sáez, M. José, Arias-Cabrales, Carlos, Buxeda, Anna, Hernandez, José Luís, Riera, Marta, Sanz, Sara, Alari-Pahissa, Elisenda, Federico-Vega, Judith, Eguía, Jorge, Pascual, Julio, Redondo-Pachón, Dolores, and Crespo, Marta
- Published
- 2024
- Full Text
- View/download PDF
3. Clinical and molecular spectrum of v-lesion
- Author
-
Buxeda, Anna, Crespo, Marta, Chamoun, Betty, Gimeno, Javier, Torres, Irina B., Redondo-Pachón, Dolores, Riera, Marta, Burballa, Carla, Pascual, Julio, Mengel, Michael, Adam, Benjamin A., and Pérez-Sáez, María José
- Published
- 2024
- Full Text
- View/download PDF
4. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
- Author
-
Mitra, Sandip, Jayanti, Anuradha, Vart, Priya, Coca, Armando, Gallieni, Maurizio, Øvrehus, Marius Altern, Midtvedt, Karsten, Abd ElHafeez, Samar, Gandolfini, Iliaria, Büttner, Stefan, Franssen, Casper FM, Hemmelder, Marc H, van der Net, Jeroen B, Essig, Marie, du Buf-Vereijken, Peggy WG, van Ginneken, Betty, Vogt, Nanda Maas Liffert, van Jaarsveld, Brigit C, Jager, Kitty J, Bemelman, Frederike J, Klingenberg-Salahova, Farah, Heenan-Vos, Frederiek, Vervloet, Marc G, Nurmohamed, Azam, Abramowicz, Daniel, Maoujoud, Sabine Verhofstede Omar, Malfait, Thomas, Fialova, Jana, Melilli, Edoardo, Favà, Alexandre, Cruzado, Josep M, Perez, Nuria Montero, Lips, Joy, Krepel, Harmen, Adilovic, Harun, Hengst, Maaike, Rydzewski, rzej, Gellert, Ryszard, Oliveira, João, Alferes, Daniela G, Zakharova, Elena V, Ambuehl, Patrice Max, Walker, rea, Winzeler, Rebecca, Lepeytre, Fanny, Rabaté, Clémentine, Rostoker, Guy, Marques, Sofia, Azasevac, Tijana, Katicic, Dajana, Dam, Marc ten, Krüger, Thilo, Brzosko, Szymon, Zanen, Adriaan L, Logtenberg, Susan JJ, Fricke, Lutz, Slebe, Jeroen JP, Kemlin, Delphine, van de Wetering, Jacqueline, Reinders, Marlies EJ, Eiselt, Jaromir, Kielberger, Lukas, El-Wakil, Hala S, Verhoeven, Martine AM, Canal, Cristina, Facundo, Carme, Ramos, Ana M, Debska-Slizien, Alicja, Veldhuizen, Nicoline MH, Tigka, Eirini, Konsta, Maria Anna Polyzou, Panagoutsos, Stylianos, Mallamaci, Francesca, Postorino, Adele, Cambareri, Francesco, Covic, Adrian, Matceac, Irina, Nistor, Ionut, Cordos, Monica, Groeneveld, JHM, van Buren, Jolanda Jousma Marjolijn, Pereira, Fritz Diekmann Tiago Assis, Santos, Augusto Cesar S, Arias-Cabrales, Carlos, Crespo, Marta, Llinàs-Mallol, Laura, Buxeda, Anna, Tàrrega, Carla Burballa, Redondo-Pachon, Dolores, Jimenez, Maria Dolores Arenas, Hofstra, Julia M, Franco, Antonio, Arroyo, David, Rodríguez-Ferrero, Maria Luisa, Manzanos, Sagrario Balda, Haridian Sosa Barrios, R, Ávila, Gonçalo, Laranjinha, Ivo, Mateus, Catarina, and Lemahieu, Wim
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Transplantation ,Clinical Research ,Kidney Disease ,Prevention ,Renal and urogenital ,Good Health and Well Being ,Aged ,COVID-19 ,Hospitalization ,Humans ,Oxygen Saturation ,Registries ,Renal Replacement Therapy ,SARS-CoV-2 ,Triage ,dialysis ,kidney ,mortality ,second presentation ,transplantation ,ERACODA Collaborators ,Urology & Nephrology ,Clinical sciences - Abstract
BackgroundPatients on kidney replacement therapy (KRT) are at very high risk of coronavirus disease 2019 (COVID-19). The triage pathway for KRT patients presenting to hospitals with varying severity of COVID-19 illness remains ill-defined. We studied the clinical characteristics of patients at initial and subsequent hospital presentations and the impact on patient outcomes.MethodsThe European Renal Association COVID-19 Database (ERACODA) was analysed for clinical and laboratory features of 1423 KRT patients with COVID-19 either hospitalized or non-hospitalized at initial triage and those re-presenting a second time. Predictors of outcomes (hospitalization, 28-day mortality) were then determined for all those not hospitalized at initial triage.ResultsAmong 1423 KRT patients with COVID-19 [haemodialysis (HD), n = 1017; transplant, n = 406), 25% (n = 355) were not hospitalized at first presentation due to mild illness (30% HD, 13% transplant). Of the non-hospitalized patients, only 10% (n = 36) re-presented a second time, with a 5-day median interval between the two presentations (interquartile range 2-7 days). Patients who re-presented had worsening respiratory symptoms, a decrease in oxygen saturation (97% versus 90%) and an increase in C-reactive protein (26 versus 73 mg/L) and were older (72 vs 63 years) compared with those who did not return a second time. The 28-day mortality between early admission (at first presentation) and deferred admission (at second presentation) was not significantly different (29% versus 25%; P = 0.6). Older age, prior smoking history, higher clinical frailty score and self-reported shortness of breath at first presentation were identified as risk predictors of mortality when re-presenting after discharge at initial triage.ConclusionsThis study provides evidence that KRT patients with COVID-19 and mild illness can be managed effectively with supported outpatient care and with vigilance of respiratory symptoms, especially in those with risk factors for poor outcomes. Our findings support a risk-stratified clinical approach to admissions and discharges of KRT patients presenting with COVID-19 to aid clinical triage and optimize resource utilization during the ongoing pandemic.
- Published
- 2021
5. Evolution of kidney allograft loss causes over 40 years (1979–2019)
- Author
-
Redondo-Pachón, Dolores, Calatayud, Emma, Buxeda, Anna, Pérez-Sáez, María José, Arias-Cabrales, Carlos, Gimeno, Javier, Burballa, Carla, Mir, Marisa, Llinàs-Mallol, Laura, Outon, Sara, Pascual, Julio, and Crespo, Marta
- Published
- 2023
- Full Text
- View/download PDF
6. Evolución de las causas de pérdida del injerto en trasplante renal durante 40 años (1979-2019)
- Author
-
Redondo-Pachón, Dolores, Calatayud, Emma, Buxeda, Anna, Pérez-Sáez, María José, Arias-Cabrales, Carlos, Gimeno, Javier, Burballa, Carla, Mir, Marisa, Llinàs-Mallol, Laura, Outon, Sara, Pascual, Julio, and Crespo, Marta
- Published
- 2023
- Full Text
- View/download PDF
7. Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration
- Author
-
Buxeda, Anna, Llinàs-Mallol, Laura, Gimeno, Javier, Redondo-Pachón, Dolores, Arias-Cabrales, Carlos, Burballa, Carla, Puche, Adrián, López-Botet, Miguel, Yélamos, José, Vilches, Carlos, Naesens, Maarten, Pérez-Sáez, María José, Pascual, Julio, and Crespo, Marta
- Published
- 2023
- Full Text
- View/download PDF
8. Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring
- Author
-
Kikić, Željko, Adam, Benjamin A., Buxeda, Anna, Lefaucheur, Carmen, Loupy, Alexandre, Regele, Heinz, Cejka, Daniel, Haas, Mark, Colvin, Robert B., and Mengel, Michael
- Published
- 2023
- Full Text
- View/download PDF
9. Frailty in kidney transplant candidates: a comparison between physical frailty phenotype and FRAIL scales
- Author
-
Pérez-Sáez, María José, Dávalos-Yerovi, Vanesa, Redondo-Pachón, Dolores, Arias-Cabrales, Carlos E., Faura, Anna, Bach, Anna, Buxeda, Anna, Burballa, Carla, Junyent, Ernestina, Nogués, Xavier, Crespo, Marta, Marco, Ester, Rodríguez-Mañas, Leocadio, and Pascual, Julio
- Published
- 2022
- Full Text
- View/download PDF
10. #2239 Identification of non-HLA antibodies associated with the development of antibody-mediated damage after kidney transplantation
- Author
-
Solà-Porta, Eulàlia, primary, Pérez-Saéz, María José, additional, Redondo-Pachón, Dolores, additional, Eguía, Jorge, additional, Caro, José Luis, additional, Federico-Vega, Judith, additional, Gimeno, Javier, additional, Buxeda, Anna, additional, Burballa, Carla, additional, and Crespo, Marta, additional
- Published
- 2024
- Full Text
- View/download PDF
11. #2461 KIR-HLA-I genetic mismatch and the development of antibody-mediated rejection and microvascular inflammation after renal transplantation
- Author
-
Federico-Vega, Judith, primary, Alari-Pahissa, Elisenda, additional, Bello, Victor, additional, Buxeda, Anna, additional, Gimeno, Javier, additional, Sanz-Ureña, Sara, additional, Medina-Jaramillo, Andrea, additional, Redondo-Pachón, Dolores, additional, Pérez-Sáez, Maria José, additional, Vilches, Carlos, additional, López-Botet, Miguel, additional, and Crespo, Marta, additional
- Published
- 2024
- Full Text
- View/download PDF
12. #3077 Activity and chronicity index as graft lost predictors in kidney transplant with antibody mediated rejection or isolated microvascular inflammation
- Author
-
Tarrega, Carla Burballa, primary, Morcillo, Sofia, additional, Buxeda, Anna, additional, Huacon, Betty Odette Chamoun, additional, Alari-Pahissa, Elisenda, additional, Sanz-Ureña, Sara, additional, Federico, Judit, additional, Redondo-Pachón, Dolores, additional, Pérez-Saéz, María José, additional, and Crespo, Marta, additional
- Published
- 2024
- Full Text
- View/download PDF
13. #2806 Role of non-HLA antibodies in pre-transplant evaluation of antibody-mediated damage risk
- Author
-
Solà-Porta, Eulàlia, primary, Pérez-Saéz, María José, additional, Redondo-Pachón, Dolores, additional, Eguía, Jorge, additional, Caro, José Luis, additional, Federico-Vega, Judith, additional, Gimeno, Javier, additional, Buxeda, Anna, additional, Burballa, Carla, additional, and Crespo, Marta, additional
- Published
- 2024
- Full Text
- View/download PDF
14. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
- Author
-
Buxeda, Anna, Arias-Cabrales, Carlos, Pérez-Sáez, María José, Cacho, Judit, Cabello Pelegrin, Sheila, Melilli, Edoardo, Aladrén, María José, Galeano, Cristina, Lorenzo, Inmaculada, Mazuecos, Auxiliadora, Saura, Isabel María, Franco, Antonio, Ruiz-Fuentes, María del Carmen, Sánchez-Cámara, Luis Alberto, Siverio, Orlando, Martin, María Luisa, González-García, Elena, López, Verónica, Martin-Moreno, Paloma Leticia, Moina, Iñigo, Moral Berrio, Esperanza, Moreso, Francesc, Portolés, José María, Santana-Estupiñán, Raquel, Zárraga, Sofía, Canal, Cristina, Sánchez-Álvarez, Emilio, Pascual, Julio, and Crespo, Marta
- Published
- 2021
- Full Text
- View/download PDF
15. Corrigendum to “Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration” [American Journal of Transplantation 23 (2023) 464–474]
- Author
-
Buxeda, Anna, primary, Llinàs-Mallol, Laura, additional, Gimeno, Javier, additional, Redondo-Pachón, Dolores, additional, Arias-Cabrales, Carlos, additional, Burballa, Carla, additional, Puche, Adrián, additional, López-Botet, Miguel, additional, Yélamos, José, additional, Vilches, Carlos, additional, Naesens, Maarten, additional, Pérez-Sáez, María José, additional, Pascual, Julio, additional, and Crespo, Marta, additional
- Published
- 2023
- Full Text
- View/download PDF
16. Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy
- Author
-
Rodrigo, Emilio, primary, Quintana, Luis F, additional, Vázquez-Sánchez, Teresa, additional, Sánchez-Fructuoso, Ana, additional, Buxeda, Anna, additional, Gavela, Eva, additional, Cazorla, Juan M, additional, Cabello, Sheila, additional, Beneyto, Isabel, additional, López-Oliva, María O, additional, Diekmann, Fritz, additional, Gómez-Ortega, José M, additional, Calvo Romero, Natividad, additional, Pérez-Sáez, María J, additional, Sancho, Asunción, additional, Mazuecos, Auxiliadora, additional, Espí-Reig, Jordi, additional, Jiménez, Carlos, additional, and Hernández, Domingo, additional
- Published
- 2023
- Full Text
- View/download PDF
17. Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy.
- Author
-
Rodrigo, Emilio, Quintana, Luis F, Vázquez-Sánchez, Teresa, Sánchez-Fructuoso, Ana, Buxeda, Anna, Gavela, Eva, Cazorla, Juan M, Cabello, Sheila, Beneyto, Isabel, López-Oliva, María O, Diekmann, Fritz, Gómez-Ortega, José M, Romero, Natividad Calvo, Pérez-Sáez, María J, Sancho, Asunción, Mazuecos, Auxiliadora, Espí-Reig, Jordi, Jiménez, Carlos, and Hernández, Domingo
- Subjects
IGA glomerulonephritis ,KIDNEY transplantation ,CHRONIC kidney failure ,INFLAMMATION ,GRAFT survival ,KIDNEY diseases - Abstract
Background Immunoglobulin A nephropathy (IgAN) is the most frequent recurrent disease in kidney transplant recipients and its recurrence contributes to reducing graft survival. Several variables at the time of recurrence have been associated with a higher risk of graft loss. The presence of clinical or subclinical inflammation has been associated with a higher risk of kidney graft loss, but it is not precisely known how it influences the outcome of patients with recurrent IgAN. Methods We performed a multicentre retrospective study including kidney transplant recipients with biopsy-proven recurrence of IgAN in which Banff and Oxford classification scores were available. 'Tubulo-interstitial inflammation' (TII) was defined when 't' or 'i' were ≥2. The main endpoint was progression to chronic kidney disease (CKD) stage 5 or to death censored-graft loss (CKD5/DCGL). Results A total of 119 kidney transplant recipients with IgAN recurrence were included and 23 of them showed TII. Median follow-up was 102.9 months and 39 (32.8%) patients reached CKD5/DCGL. TII related to a higher risk of CKD5/DCGL (3 years 18.0% vs 45.3%, log-rank 7.588, P = .006). After multivariate analysis, TII remained related to the risk of CKD5/DCGL (HR 2.344, 95% CI 1.119–4.910, P = .024) independently of other histologic and clinical variables. Conclusions In kidney transplant recipients with IgAN recurrence, TII contributes to increasing the risk of CKD5/DCGL independently of previously well-known variables. We suggest adding TII along with the Oxford classification to the clinical variables to identify recurrent IgAN patients at increased risk of graft loss who might benefit from intensified immunosuppression or specific IgAN therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Association of obesity with 3-month mortality in kidney failure patients with COVID-19
- Author
-
Tantisattamo, Ekamol, Imhof, Celine, Jager, Kitty J., Hilbrands, Luuk B., Guidotti, Rebecca, Islam, Mahmud, Katicic, Dajana, Konings, Constantijn, Molenaar, Femke M., Nistor, Ionut, Noordzij, Marlies, Rodríguez Ferrero, Mariá Luisa, Verhoeven, Martine A. M., de Vries, Aiko P. J., Kalantar-Zadeh, Kamyar, Gansevoort, Ron T., Vart, Priya, van der Net, Jeroen B., Essig, Marie, du Buf-Vereijken, Peggy W. G., van Ginneken, Betty, Maas, Nanda, van Jaarsveld, Brigit C., Bemelman, Frederike J., Klingenberg-Salahova, Farah, Heenan-Vos, Frederiek, Vervloet, Marc G., Nurmohamed, Azam, Vogt, Liffert, Abramowicz, Daniel, Verhofstede, Sabine, Maoujoud, Omar, Malfait, Thomas, Fialova, Jana, Melilli, Edoardo, Favà, Alexandre, Cruzado, Josep M., Perez, Nuria Montero, Lips, Joy, Krepel, Harmen, Adilovic, Harun, Radulescu, Daniela, Hengst, Maaike, Rydzewski, Andrzej, Braconnier, Philippe, Weis, Daniel, Gellert, Ryszard, Oliveira, Joaõ, Alferes, Daniela G., Zakharova, Elena V., Ambuehl, Patrice Max, Walker, Andrea, Lepeytre, Fanny, Rabate, Clementine, Rostoker, Guy, Marques, Sofia, Azasevac, Tijana, Majstorovic, Gordana Strazmester, ten Dam, Marc, Krüger, Thilo, Brzosko, Szymon, Liakopoulos, Vassilios, Zanen, Adriaan L., Logtenberg, Susan J. J., Fricke, Lutz, Kuryata, Olexandr, Slebe, Jeroen J. P., Elhafeez, Samar Abd, Kemlin, Delphine, van de Wetering, Jacqueline, Reinders, Marlies E. J., Hesselink, Dennis A., Kal-van Gestel, J., Eiselt, Jaromir, Kielberger, Lukas, el-Wakil, Hala S., Logan, Ian, Canal, Cristina, Facundo, Carme, Ramos, Ana M., Debska-Slizien, Alicja, Veldhuizen, Nicoline M. H., Tigka, Eirini, Konsta, Maria Anna Polyzou, Panagoutsos, Stylianos, Mallamaci, Francesca, Postorino, Adele, Cambareri, Francesco, Matceac, Irina, Covic, Adrian, Groeneveld, J. H. M., Jousma, Jolanda, van Buren, Marjolijn, Diekmann, Fritz, Oppenheimer, Federico, Blasco, Miquel, Pereira, Tiago Assis, Santos, Augusto Cesar S., Arias-Cabrales, Carlos, Crespo, Marta, Llinàs-Mallol, Laura, Buxeda, Anna, Tàrrega, Carla Burballa, Redondo-Pachon, Dolores, Jimenez, Maria Dolores Arenas, Mendoza-Valderrey, Alberto, Martins, Ana Cristina, Mateus, Catarina, Alvila, Goncalo, Laranjinha, Ivo, Hofstra, Julia M., Siezenga, Machiel A., Franco, Antonio, Arroyo, David, Castellano, Sandra, Manzanos, Sagrario Balda, Haridian Sosa Barrios, R., Lemahieu, Wim, Bartelet, Karlijn, Dirim, Ahmet Burak, Demir, Erol, Sever, Mehmet Sukru, Turkmen, Aydin, Safak, Seda, Hollander, Daan A. M. J., Büttner, Stefan, Meziyerh, Soufian, van der Helm, Danny, Mallat, Marko, Bouwsma, Hanneke, Sridharan, Sivakumar, Petruliene, Kristina, Maloney, Sharon-Rose, Verberk, Iris, van der Sande, Frank M., Christiaans, Maarten H. L., Hemmelder, Marc H., Kumar, Mohan N., di Luca, Marina, Tuǧlular, Serhan Z., Ziekenhuis, Martini, Kramer, Andrea B., Beerenhout, Charles, Luik, Peter T., Kerschbaum, Julia, Tiefenthaler, Martin, Watschinger, Bruno, Adema, Aaltje Y., Stepanov, Vadim A., Zulkarnaev, Alexey B., Turkmen, Kultigin, Gandolfini, Ilaria, Maggiore, Umberto, Fliedner, Anselm, Åsberg, Anders, Mjoen, Geir, Miyasato, Hitoshi, de Fijter, Carola W. H., Mongera, Nicola, Pini, Stefano, de Biase, Consuelo, Kerckhoffs, Angele, Els van de Logt, Anne, Maas, Rutger, Duivenvoorden, Raphaël, Lebedeva, Olga, Lopez, Veronica, Reichert, Louis J. M., Verhave, Jacobien, Titov, Denis, Parshina, Ekaterina V., Zanoli, Luca, Marcantoni, Carmelita, van Kempen, Gijs, van Gils-Verrij, Liesbeth E. A., Harty, John C., Meurs, Marleen, Myslak, Marek, Battaglia, Yuri, Lentini, Paolo, den Deurwaarder, Edwin, Stendahl, Maria, Rahimzadeh, Hormat, Schouten, Marcel, Rychlik, Ivan, Cabezas-Reina, Carlos J., Roca, Ana Maria, Nauta, Ferdau, Sahin, Idris, Goffin, Eric, Kanaan, Nada, Labriola, Laura, Devresse, Arnaud, Diaz-Mareque, Anabel, Coca, Armando, de Arriba, Gabriel, Meijers, Björn K. I., Naesens, Maarten, Kuypers, Dirk, Desschans, Bruno, Tonnerlier, Annelies, Wissing, Karl M., Dedinska, Ivana, Pessolano, Giuseppina, Malik, Shafi, Dounousi, Evangelia, Papachristou, Evangelos, Berger, Stefan P., Meijer, Esther, Sanders, Jan Stephan F., Franssen, Casper F. M., Özyilmaz, Akin, Ponikvar, Jadranka Buturović, Pernat, Andreja Marn, Kovac, Damjan, Arnol, Miha, Ekart, Robert, Abrahams, Alferso C., van Zuilen, Arjan D., Meijvis, Sabine C. A., Dolmans, Helma, Esposito, Pasquale, Krzesinski, Jean-Marie, Barahira, Jean Damacène, Gallieni, Maurizio, Martin-Moreno, Paloma Leticia, Guglielmetti, Gabriele, Guzzo, Gabriella, Toapanta, Nestor, Soler, Maria Jose, Luik, Antinus J., van Kuijk, Willi H. M., Stikkelbroeck, Lonneke W. H., Hermans, Marc M. H., Rimsevicius, Laurynas, Righetti, Marco, Heitink-ter Braak, Nicole, Medical Informatics, APH - Aging & Later Life, APH - Quality of Care, APH - Global Health, ACS - Pulmonary hypertension & thrombosis, Nephrology, ACS - Microcirculation, APH - Health Behaviors & Chronic Diseases, Clinical sciences, UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie, ACS - Diabetes & metabolism, Internal Medicine, Cardiovascular Centre (CVC), Groningen Kidney Center (GKC), van der Net, Jeroen B, Essig, Marie, du Buf-Vereijken, Peggy W G, van Ginneken, Betty, Maas, Nanda, van Jaarsveld, Brigit C, Bemelman, Frederike J, Klingenberg-Salahova, Farah, Heenan-Vos, Frederiek, Vervloet, Marc G, Nurmohamed, Azam, Vogt, Liffert, Abramowicz, Daniel, Verhofstede, Sabine, Maoujoud, Omar, Malfait, Thomas, Fialova, Jana, Melilli, Edoardo, Favà, Alexandre, Cruzado, Josep M, Perez, Nuria Montero, Lips, Joy, Krepel, Harmen, Adilovic, Harun, Radulescu, Daniela, Hengst, Maaike, Rydzewski, Andrzej, Braconnier, Philippe, Weis, Daniel, Gellert, Ryszard, Oliveira, João, Alferes, Daniela G, Zakharova, Elena V, Ambuehl, Patrice Max, Walker, Andrea, Lepeytre, Fanny, Rabaté, Clémentine, Rostoker, Guy, Marques, Sofia, Azasevac, Tijana, Majstorovic, Gordana Strazmester, Ten Dam, Marc, Krüger, Thilo, Brzosko, Szymon, Liakopoulos, Vassilios, Zanen, Adriaan L, Logtenberg, Susan J J, Fricke, Lutz, Kuryata, Olexandr, Slebe, Jeroen J P, ElHafeez, Samar Abd, Kemlin, Delphine, van de Wetering, Jacqueline, Reinders, Marlies E J, Hesselink, Dennis A, Kal-van Gestel, J., Eiselt, Jaromir, Kielberger, Lukas, El-Wakil, Hala S, Logan, Ian, Canal, Cristina, Facundo, Carme, Ramos, Ana M, Debska-Slizien, Alicja, Veldhuizen, Nicoline M H, Tigka, Eirini, Konsta, Maria Anna Polyzou, Panagoutsos, Stylianos, Mallamaci, Francesca, Postorino, Adele, Cambareri, Francesco, Matceac, Irina, Covic, Adrian, Groeneveld, J H M, Jousma, Jolanda, van Buren, Marjolijn, Diekmann, Fritz, Oppenheimer, Federico, Blasco, Miquel, Pereira, Tiago Assis, Santos, Augusto Cesar S, Arias-Cabrales, Carlos, Crespo, Marta, Llinàs-Mallol, Laura, Buxeda, Anna, Tàrrega, Carla Burballa, Redondo-Pachon, Dolores, Jimenez, Maria Dolores Arenas, Mendoza-Valderrey, Alberto, Martins, Ana Cristina, Mateus, Catarina, Alvila, Goncalo, Laranjinha, Ivo, Hofstra, Julia M, Siezenga, Machiel A, Franco, Antonio, Arroyo, David, Castellano, Sandra, Manzanos, Sagrario Balda, Haridian Sosa Barrios, R., Lemahieu, Wim, Bartelet, Karlijn, Dirim, Ahmet Burak, Demir, Erol, Sever, Mehmet Sukru, Turkmen, Aydin, Şafak, Seda, Hollander, Daan A M J, Büttner, Stefan, Meziyerh, Soufian, van der Helm, Danny, Mallat, Marko, Bouwsma, Hanneke, Sridharan, Sivakumar, Petrulienė, Kristina, Maloney, Sharon-Rose, Verberk, Iris, van der Sande, Frank M, Christiaans, Maarten H L, Hemmelder, Marc H, Kumar N, Mohan, Di Luca, Marina, Tuğlular, Serhan Z, Ziekenhuis, Martini, Kramer, Andrea B, Beerenhout, Charles, Luik, Peter T, Kerschbaum, Julia, Tiefenthaler, Martin, Watschinger, Bruno, Adema, Aaltje Y, Stepanov, Vadim A, Zulkarnaev, Alexey B, Turkmen, Kultigin, Gandolfini, Ilaria, Maggiore, Umberto, Fliedner, Anselm, Åsberg, Anders, Mjoen, Geir, Miyasato, Hitoshi, de Fijter, Carola W H, Mongera, Nicola, Pini, Stefano, de Biase, Consuelo, Kerckhoffs, Angele, Els van de Logt, Anne, Maas, Rutger, Duivenvoorden, Raphaël, Lebedeva, Olga, Lopez, Veronica, Reichert, Louis J M, Verhave, Jacobien, Titov, Denis, Parshina, Ekaterina V, Zanoli, Luca, Marcantoni, Carmelita, van Kempen, Gijs, van Gils-Verrij, Liesbeth E A, Harty, John C, Meurs, Marleen, Myslak, Marek, Battaglia, Yuri, Lentini, Paolo, den Deurwaarder, Edwin, Stendahl, Maria, Rahimzadeh, Hormat, Schouten, Marcel, Rychlik, Ivan, Cabezas-Reina, Carlos J, Roca, Ana Maria, Nauta, Ferdau, Sahin, İdris, Goffin, Eric, Kanaan, Nada, Labriola, Laura, Devresse, Arnaud, Diaz-Mareque, Anabel, Coca, Armando, de Arriba, Gabriel, Meijers, Björn K I, Naesens, Maarten, Kuypers, Dirk, Desschans, Bruno, Tonnerlier, Annelies, Wissing, Karl M, Dedinska, Ivana, Pessolano, Giuseppina, Malik, Shafi, Dounousi, Evangelia, Papachristou, Evangelos, Berger, Stefan P, Meijer, Esther, Sanders, Jan Stephan F, Franssen, Casper F M, Özyilmaz, Akin, Ponikvar, Jadranka Buturović, Pernat, Andreja Marn, Kovac, Damjan, Arnol, Miha, Ekart, Robert, Abrahams, Alferso C, van Zuilen, Arjan D, Meijvis, Sabine C A, Dolmans, Helma, Esposito, Pasquale, Krzesinski, Jean-Marie, Barahira, Jean Damacène, Gallieni, Maurizio, Martin-Moreno, Paloma Leticia, Guglielmetti, Gabriele, Guzzo, Gabriella, Toapanta, Nestor, Soler, Maria Jose, Luik, Antinus J, van Kuijk, Willi H M, Stikkelbroeck, Lonneke W H, Hermans, Marc M H, Rimševičius, Laurynas, Righetti, Marco, and Heitink-Ter Braak, Nicole
- Subjects
Transplantation ,COVID-19 ,infectious diseases ,mortality ,DIALYSIS PATIENTS ,kidney failure ,BODY-MASS INDEX ,obesity paradox ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,TRANSPLANT ,SDG 3 - Good Health and Well-being ,Nephrology ,ERACODA ,reverse epidemiology ,Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] - Abstract
Background In the general population with coronavirus disease 2019 (COVID-19), obesity is associated with an increased risk of mortality. Given the typically observed obesity paradox among patients on kidney function replacement therapy (KFRT), especially dialysis patients, we examined the association of obesity with mortality among dialysis patients or living with a kidney transplant with COVID-19. Methods Data from the European Renal Association COVID-19 Database (ERACODA) were used. KFRT patients diagnosed with COVID-19 between 1 February 2020 and 31 January 2021 were included. The association of Quetelet's body mass index (BMI) (kg/m2), divided into: Results In 3160 patients on KFRT (mean age: 65 years, male: 61%), 99 patients were lean, 1151 normal weight (reference), 1160 overweight, 525 obese I and 225 obese II/III. During follow-up of 3 months, 28, 20, 21, 23 and 27% of patients died in these categories, respectively. In the fully adjusted model, the hazard ratios (HRs) for 3-month mortality were 1.65 [95% confidence interval (CI): 1.10, 2.47], 1 (ref.), 1.07 (95% CI: 0.89, 1.28), 1.17 (95% CI: 0.93, 1.46) and 1.71 (95% CI: 1.27, 2.30), respectively. Results were similar among dialysis patients (N = 2343) and among those living with a kidney transplant (N = 817) (Pinteraction = 0.99), but differed by sex (Pinteraction = 0.019). In males, the HRs for the association of aforementioned BMI categories with 3-month mortality were 2.07 (95% CI: 1.22, 3.52), 1 (ref.), 0.97 (95% CI: 0.78. 1.21), 0.99 (95% CI: 0.74, 1.33) and 1.22 (95% CI: 0.78, 1.91), respectively, and in females corresponding HRs were 1.34 (95% CI: 0.70, 2.57), 1 (ref.), 1.31 (95% CI: 0.94, 1.85), 1.54 (95% CI: 1.05, 2.26) and 2.49 (95% CI: 1.62, 3.84), respectively. Conclusion In KFRT patients with COVID-19, on dialysis or a kidney transplant, obesity is associated with an increased risk of mortality at 3 months. This is in contrast to the obesity paradox generally observed in dialysis patients. Additional studies are required to corroborate the sex difference in the association of obesity with mortality.
- Published
- 2022
19. #5393 INFLUENCE OF CELLULAR INFLAMMATION ON THE OUTCOME OF KIDNEY TRANSPLANTATION AFTER RECURRENCE OF IGA NEPHROPATHY
- Author
-
Vázquez, Teresa, primary, Rodrigo, Emilio, additional, Porras, Luis Fernando Quintana, additional, Fructuoso, Ana Sanchez, additional, Gomez-Ortega, Jose María, additional, Buxeda, Anna, additional, Gavela, Eva, additional, Castello, Maria Isabel Beneyto, additional, Oliva, Maria Ovidia Lopez, additional, and Hernández, Domingo, additional
- Published
- 2023
- Full Text
- View/download PDF
20. High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation
- Author
-
Buxeda, Anna, primary, Caravaca-Fontán, Fernando, additional, Vigara, Luis Alberto, additional, Pérez-Canga, José Luis, additional, Calatayud, Emma, additional, Coloma, Ana, additional, Mazuecos, Auxiliadora, additional, Rodrigo, Emilio, additional, Sancho, Asunción, additional, Melilli, Edoardo, additional, Praga, Manuel, additional, Pérez-Sáez, María José, additional, and Pascual, Julio, additional
- Published
- 2023
- Full Text
- View/download PDF
21. Increased mortality after kidney transplantation in mildly frail recipients
- Author
-
Pérez-Sáez, María José, Arias-Cabrales, Carlos E., Redondo-Pachón, Dolores, Burballa, Carla, Buxeda, Anna, Bach, Anna, Faura, Anna, Junyent, Ernestina, Marco, Ester, Rodríguez-Mañas, Leocadio, Crespo Barrio, Marta, Pascual, Julio, and Universitat Autònoma de Barcelona
- Subjects
Transplantation ,Survival ,Nephrology ,Ttransplant ,Frailty phenotype ,Transplant ,Fried - Abstract
Background Physical Frailty Phenotype (PFP) is the most used frailty instrument among kidney transplant recipients, classifying patients as pre-frail if they have 1–2 criteria and as frail if they have ≥3. However, different definitions of robustness have been used among renal patients, including only those who have 0 criteria, or those with 0–1 criteria. Our aim was to determine the impact of one PFP criterion on transplant outcomes. Methods We undertook a retrospective study of 296 kidney transplant recipients who had been evaluated for frailty by PFP at the time of evaluating for transplantation. Results Only 30.4% of patients had 0 criteria, and an additional 42.9% showed one PFP criterion. As PFP score increased, a higher percentage of women and cerebrovascular disease were found. Recipients with 0–1 criteria had lower 1-year mortality after transplant than those with ≥2 (1.8% vs 10.1%), but this difference was already present when we only considered those who scored 0 (mortality 1.1%) and 1 (mortality 2.4%) separately. The multivariable analysis confirmed that one PFP criterion was associated to a higher risk of patient death after kidney transplantation [hazard ratio 3.52 (95% confidence interval 1.03–15.9)]. Conclusions Listed kidney transplant candidates frequently show only one PFP frailty criterion. This has an independent impact on patient survival after transplantation.
- Published
- 2022
22. THSD7A-positive membranous nephropathy after kidney transplantation: A case report
- Author
-
Solà-Porta, Eulàlia, primary, Buxeda, Anna, additional, Lop, Joan, additional, Naranjo-Hans, Dolores, additional, Gimeno, Javier, additional, Lloveras-Rubio, Belén, additional, Pérez-Sáez, María José, additional, Redondo-Pachón, Dolores, additional, and Crespo, Marta, additional
- Published
- 2023
- Full Text
- View/download PDF
23. Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine
- Author
-
Arias-Cabrales, Carlos, primary, Folgueiras, Montserrat, additional, Faura, Anna, additional, Eguia, Jorge, additional, Padilla, Eduardo, additional, Hurtado, Sara, additional, Ribera, Laura, additional, Echeverria-Esnal, Daniel, additional, Pérez-Sáez, María José, additional, Redondo-Pachón, Dolores, additional, Burballa, Carla, additional, Buxeda, Anna, additional, Llinàs-Mallol, Laura, additional, Cao, Higini, additional, Barbosa, Francesc, additional, Rovira, Xavier, additional, Cima, Florencia, additional, Pascual, Julio, additional, and Crespo, Marta, additional
- Published
- 2022
- Full Text
- View/download PDF
24. COVID-19-related mortality in kidney transplant and haemodialysis patients
- Author
-
Goffin, Eric, Candellier, Alexandre, Vart, Priya, Noordzij, Marlies, Arnol, Miha, Covic, Adrian, Lentini, Paolo, Malik, Shafi, Reichert, Louis J., Sever, Mehmet S., Watschinger, Bruno, Jager, Kitty J., Gansevoort, Ron T., van der Net, Jeroen B., Essig, Marie, du Buf-Vereijken, Peggy W. G., van Ginneken, Betty, Vogt, Liffert, van Jaarsveld, Brigit C., Bemelman, Frederike J., Klingenberg-Salahova, Farah, Heenan-Vos, Frederiek, Vervloet, Marc G., Nurmohamed, Azam, Abramowicz, Daniel, Verhofstede, Sabine, Maoujoud, Omar, Malfait, Thomas, Avitum, B. Braun, Fialova, Jana, Melilli, Edoardo, Favà, Alexandre, Cruzado, Josep M., Perez, Nuria Montero, Lips, Joy, Krepel, Harmen, Adilovic, Harun, Hengst, Maaike, Rydzewski, Andrzej, Gellert, Ryszard, Oliveira, João, Alferes, Daniela G., Zakharova, Elena V., Ambuehl, Patrice Max, Walker, Andrea, Winzeler, Rebecca, Lepeytre, Fanny, Rabaté, Clémentine, Rostoker, Guy, Marques, Sofia, Azasevac, Tijana, Katicic, Dajana, ten Dam, Marc, Krüger, Thilo, Brzosko, Szymon, Zanen, Adriaan L., Logtenberg, Susan J. J., Fricke, Lutz, Slebe, Jeroen J. P., Kemlin, Delphine, van de Wetering, Jacqueline, Reinders, Marlies E. J., Eiselt, Jaromir, Kielberger, Lukas, el-Wakil, Hala S., Verhoeven, Martine A. M., Canal, Cristina, Facundo, Carme, Ramos, Ana M., Debska-Slizien, Alicja, Veldhuizen, Nicoline M. H., Tigka, Eirini, Konsta, Maria Anna Polyzou, Panagoutsos, Stylianos, Mallamaci, Francesca, Matceac, Irina, Nistor, Ionut, Cordos, Monica, Groeneveld, J. H. M., Jousma, Jolanda, van Buren, Marjolijn, Elhafeez, Samar Abd, Diekmann, Fritz, Pereira, Tiago Assis, Santos, Augusto Cesar S., Arias-Cabrales, Carlos, Crespo, Marta, Llinàs-Mallol, Laura, Buxeda, Anna, Tàrrega, Carla Burballa, Redondo-Pachon, Dolores, Jimenez, Maria Dolores Arenas, Hofstra, Julia M., Franco, Antonio, Arroyo, David, Rodríguez-Ferrero, Maria Luisa, Manzanos, Sagrario Balda, Barrios, R. Haridian Sosa, Ávila, Gonçalo, Laranjinha, Ivo, Mateus, Catarina, Lemahieu, Wim, Dirim, Ahmet Burak, Demir, Erol, Å afak, Seda, Turkmen, Aydin, Hollander, Daan A. M. J., Büttner, Stefan, de Vries, Aiko P. J., Meziyerh, Soufian, van der Helm, Danny, Mallat, Marko, Bouwsma, Hanneke, Sridharan, Sivakumar, Petruliene, Kristina, Maloney, Sharon-Rose, Verberk, Iris, van der Sande, Frank M., Christiaans, Maarten H. L., Hemmelder, Marc, Kumar, Mohan N., di Luca, Marina, Tuǧlular, Serhan Z., Kramer, Andrea, Beerenhout, Charles, Luik, Peter T., Kerschbaum, Julia, Tiefenthaler, Martin, Adema, Aaltje Y., Stepanov, Vadim A., Zulkarnaev, Alexey B., Turkmen, Kultigin, Fliedner, Anselm, Åsberg, Anders, Mjoen, Geir, Miyasato, Hitoshi, de Fijter, Carola W. H., Mongera, Nicola, Pini, Stefano, de Biase, Consuelo, Duivenvoorden, Raphaël, Hilbrands, Luuk, Kerckhoffs, Angele, Maas, Rutger, Lebedeva, Olga, Lopez, Veronica, Verhave, Jacobien, Titov, Denis, Parshina, Ekaterina V., Zanoli, Luca, Marcantoni, Carmelita, van Gils-Verrij, Liesbeth E. A., Harty, John C., Meurs, Marleen, Myslak, Marek, Battaglia, Yuri, den Deurwaarder, Edwin, Stendahl, Maria, Rahimzadeh, Hormat, Schouten, Marcel, Rychlik, Ivan, Cabezas-Reina, Carlos J., Roca, Ana Maria, Nauta, Ferdau, Kanaan, Nada, Labriola, Laura, Devresse, Arnaud, Diaz-Mareque, Anabel, Coca, Armando, Meijers, Björn K. I., Naesens, Maarten, Kuypers, Dirk, Desschans, Bruno, Tonnelier, Annelies, Wissing, Karl M., de Arriba, Gabriel, Dedinska, Ivana, Pessolano, Giuseppina, Gandolfini, Ilaria, Maggiore, Umberto, Papachristou, Evangelos, Franssen, Casper F. M., Berger, Stefan P., Meijer, Esther, Özyilmaz, Akin, Sanders, Jan Stephan F., Ponikvar, Jadranka Buturović, Pernat, Andreja Marn, Kovac, Damjan, Ekart, Robert, Abrahams, Alferso C., Molenaar, Femke M., van Zuilen, Arjan D., Meijvis, Sabine C. A., Dolmans, Helma, Tantisattamos, Ekamol, Esposito, Pasquale, Krzesinski, Jean-Marie, Barahira, Jean Damacène, Gallieni, Maurizio, Sabiu, Gianmarco, Martin-Moreno, Paloma Leticia, Guglielmetti, Gabriele, Guzzo, Gabriella, Toapanta, Nestor, Luik, Antinus J., van Kuijk, Willi H. M., Stikkelbroeck, Lonneke W. H., Hermans, Marc M. H., Rimsevicius, Laurynas, Righetti, Marco, Islam, Mahmud, Braak, Nicole Heitink-Ter, UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie, Internal Medicine, Clinical sciences, Nephrology, ACS - Diabetes & metabolism, AII - Inflammatory diseases, AII - Infectious diseases, Groningen Kidney Center (GKC), Cardiovascular Centre (CVC), Medical Informatics, ACS - Pulmonary hypertension & thrombosis, APH - Aging & Later Life, APH - Quality of Care, ACS - Microcirculation, APH - Health Behaviors & Chronic Diseases, and APH - Global Health
- Subjects
medicine.medical_specialty ,kidney ,Original Article - Dialysis ,medicine.medical_treatment ,infectious diseases ,law.invention ,Kidney Failure ,SDG 3 - Good Health and Well-being ,Renal Dialysis ,Risk Factors ,law ,Internal medicine ,medicine ,Humans ,COVID-19 ,dialysis ,mortality ,transplantation ,Registries ,Renal replacement therapy ,Chronic ,AcademicSubjects/MED00340 ,Kidney transplantation ,Dialysis ,Transplantation ,SARS-CoV-2 ,business.industry ,Kidney Transplantation/adverse effects ,Hazard ratio ,medicine.disease ,Kidney Transplantation ,Intensive care unit ,Comorbidity ,Transplant Recipients ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,Kidney Failure, Chronic/therapy ,Nephrology ,Kidney Failure, Chronic ,Hemodialysis ,Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] ,business - Abstract
BACKGROUND AND AIMS: Studies examining kidney failure patients with COVID-19 reported higher mortality in hemodialysis patients than in kidney transplant recipients. However, hemodialysis patients are often older and have more comorbidities. This study investigated the association of type of kidney replacement therapy with COVID-19 severity adjusting for differences in characteristics. METHOD: Data were retrieved from the European Renal Association COVID-19 Database (ERACODA), which includes kidney replacement therapy patients diagnosed with COVID-19 from all over Europe. We included all kidney transplant recipients and hemodialysis patients who presented between February 1st and December 1st 2020 and had complete information reason for COVID-19 screening and vital status at day 28. The diagnosis of COVID-19 was made based on a PCR of a nasal or pharyngeal swab specimens and/or COVID-19 compatible findings on a lung CT scan. The association of kidney transplantation or hemodialysis with 28-day mortality was examined using Cox proportional-hazards regression models adjusted for age, sex, frailty and comorbidities. Additionally, this association was investigated in the subsets of patients that were screened because of symptoms or have had routine screening. RESULTS: A total of 1,670 patients (496 functional kidney transplant recipients and 1,174 hemodialysis patients) were examined. 16.9% of kidney transplant recipients and 23.9% of hemodialysis patients died within 28 days of presentation. In an unadjusted model, the risk of 28-day mortality was 33% lower in kidney transplant recipients compared with hemodialysis patients (hazard ratio (HR): 0.67, 95% CI: 0.52, 0.85). However, in an age, sex and frailty adjusted model, the risk of 28-day mortality was 29% higher in kidney transplant recipients (HR=1.29, 95% CI: 1.00, 1.68), whereas in a fully adjusted model the risk was even 43% higher (HR=1.43, 95% CI: 1.06, 1.93). This association in patients who were screened because of symptoms (n=1,145) was similar (fully adjusted model HR=1.46, 95% CI: 1.05, 2.04). Results were similar when other endpoints were studied (e.g. risk for hospitalization, ICU admission or mortality beyond 28 days) as well as across subgroups. Only age was found to interact significantly, suggesting that the increased mortality risk associated with kidney transplantation was especially present in elderly subjects. CONCLUSION: In this study, kidney transplant recipients had a greater risk of a more severe course of COVID-19 compared with hemodialysis patients when adjusted for age, sex and comorbidities.
- Published
- 2021
25. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
- Author
-
Vart, Priya, Duivenvoorden, Raphaël, Adema, Aaltje, Covic, Adrian, Finne, Patrik, Braak, Nicole Heijtink-ter, Laine, Kaisa, Noordzij, Marlies, Schouten, Marcel, Jager, Kitty J., Gansevoort, Ron T., van der Net, Jeroen B., Essig, Marie, du Buf-Vereijken, Peggy W. G., van Ginneken, Betty, Maas, Nanda, van Jaarsveld, Brigit C., Bemelman, Frederike J., Klingenberg-Salahova, Farah, Heenan-Vos, Frederiek, Vervloet, Marc G., Nurmohamed, Azam, Vogt, Liffert, Abramowicz, Daniel, Verhofstede, Sabine, Maoujoud, Omar, Malfait, Thomas, Fialova, Jana, Melilli, Edoardo, Favà, Alexandre, Cruzado, Josep M., Perez, Nuria Montero, Lips, Joy, Krepel, Harmen, Adilovic, Harun, Radulescu, Daniela, Hengst, Maaike, Konings, Constantijn, Rydzewski, Andrzej, Braconnier, Philippe, Weis, Daniel, Gellert, Ryszard, Oliveira, João, Alferes, Daniela G., Zakharova, Elena V., Ambühl, Patrice Max, Guidotti, Rebecca, Walker, Andrea, Lepeytre, Fanny, Rabaté, Clémentine, Rostoker, Guy, Marques, Sofia, Azasevac, Tijana, Majstorovic, Gordana Strazmester, Katicic, Dajana, ten Dam, Marc, Krüger, Thilo, Brzosko, Szymon, Liakopoulos, Vassilios, Zanen, Adriaan L., Logtenberg, Susan J. J., Fricke, Lutz, Kuryata, Olexandr, Slebe, Jeroen J. P., ElHafeez, Samar Abd, Kemlin, Delphine, van de Wetering, Jacqueline, Reinders, Marlies E. J., Hesselink, Dennis A., Kal-van Gestel, J., Eiselt, Jaromir, Kielberger, Lukas, El-Wakil, Hala S., Verhoeven, Martine, Logan, Ian, Canal, Cristina, Facundo, Carme, Ramos, Ana M., Debska-Slizien, Alicja, Veldhuizen, Nicoline M. H., Tigka, Eirini, Konsta, Maria Anna Polyzou, Panagoutsos, Stylianos, Mallamaci, Francesca, Postorino, Adele, Cambareri, Francesco, Matceac, Irina, Nistor, Ionut, Groeneveld, J. H.M., Jousma, Jolanda, van Buren, Marjolijn, Diekmann, Fritz, Oppenheimer, Federico, Blasco, Miquel, Pereira, Tiago Assis, Santos, Augusto Cesar S., Arias-Cabrales, Carlos, Crespo, Marta, Llinàs-Mallol, Laura, Buxeda, Anna, Tàrrega, Carla Burballa, Redondo-Pachon, Dolores, Jimenez, Maria Dolores Arenas, Mendoza-Valderrey, Alberto, Martins, Ana Cristina, Mateus, Catarina, Alvila, Goncalo, Laranjinha, Ivo, Hofstra, Julia M., Siezenga, Machiel A., Franco, Antonio, Arroyo, David, Castellano, Sandra, Rodríguez-Ferrero, Maria Luisa, Manzanos, Sagrario Balda, Barrios, R. Haridian Sosa, Lemahieu, Wim, Bartelet, Karlijn, Dirim, Ahmet Burak, Demir, Erol, Sever, Mehmet Sukru, Turkmen, Aydin, Şafak, Seda, Hollander, Daan A. M. J., Büttner, Stefan, de Vries, Aiko P. J., Meziyerh, Soufian, van der Helm, Danny, Mallat, Marko, Bouwsma, Hanneke, Sridharan, Sivakumar, Petrulienė, Kristina, Maloney, Sharon-Rose, Verberk, Iris, van der Sande, Frank M., Christiaans, Maarten H. L., Hemmelder, Marc H., MohanKumar, N., Di Luca, Marina, Tuğlular, Serhan Z., Kramer, Andrea B., Beerenhout, Charles, Luik, Peter T., Kerschbaum, Julia, Tiefenthaler, Martin, Watschinger, Bruno, Stepanov, Vadim A., Zulkarnaev, Alexey B., Turkmen, Kultigin, Gandolfini, Ilaria, Maggiore, Umberto, Fliedner, Anselm, Åsberg, Anders, Mjoen, Geir, Miyasato, Hitoshi, de Fijter, Carola W. H., Mongera, Nicola, Pini, Stefano, de Biase, Consuelo, Kerckhoffs, Angele, van de Logt, Anne Els, Maas, Rutger, Hilbrands, Luuk B., Lebedeva, Olga, Lopez, Veronica, Reichert, Louis J. M., Verhave, Jacobien, Titov, Denis, Parshina, Ekaterina V., Zanoli, Luca, Marcantoni, Carmelita, van Kempen, Gijs, van Gils-Verrij, Liesbeth E. A., Harty, John C., Meurs, Marleen, Myslak, Marek, Battaglia, Yuri, Lentini, Paolo, den Deurwaarder, Edwin, Stendahl, Maria, Rahimzadeh, Hormat, Rychlik, Ivan, Cabezas-Reina, Carlos J., Roca, Ana Maria, Nauta, Ferdau, Sahin, İdris, Goffin, Eric, Kanaan, Nada, Labriola, Laura, Devresse, Arnaud, Diaz-Mareque, Anabel, Coca, Armando, de Arriba, Gabriel, Meijers, Björn K. I., Naesens, Maarten, Kuypers, Dirk, Desschans, Bruno, Tonnerlier, Annelies, Wissing, Karl M., Dedinska, Ivana, Pessolano, Giuseppina, Malik, Shafi, Dounousi, Evangelia, Papachristou, Evangelos, Berger, Stefan P., Sanders, Jan Stephan F., Franssen, Casper F. M., Özyilmaz, Akin, Ponikvar, Jadranka Buturović, Pernat, Andreja Marn, Kovac, Damjan, Arnol, Miha, Ekart, Robert, Abrahams, Alferso C., Molenaar, Femke M., van Zuilen, Arjan D., Meijvis, Sabine C. A., Dolmans, Helma, Tantisattamo, Ekamol, Esposito, Pasquale, Krzesinski, Jean-Marie, Barahira, Jean Damacène, Gallieni, Maurizio, Martin-Moreno, Paloma Leticia, Guglielmetti, Gabriele, Guzzo, Gabriella, Toapanta, Nestor, Soler, Maria Jose, Luik, Antinus J., van Kuijk, Willi H. M., Stikkelbroeck, Lonneke W. H., Hermans, Marc M. H., Rimševičius, Laurynas, Righetti, Marco, Islam, Mahmud, Clinical sciences, Nephrology, Groningen Kidney Center (GKC), Cardiovascular Centre (CVC), Groningen Institute for Organ Transplantation (GIOT), Medical Informatics, APH - Aging & Later Life, APH - Quality of Care, APH - Global Health, ACS - Pulmonary hypertension & thrombosis, AII - Inflammatory diseases, ACS - Microcirculation, APH - Health Behaviors & Chronic Diseases, Internal Medicine, Department of Medicine, Clinicum, University of Helsinki, Helsinki University Hospital Area, ACS - Diabetes & metabolism, UCL - SSS/IREC/NEFR - Pôle de Néphrologie, and UCL - (SLuc) Service de néphrologie
- Subjects
Male ,kidney ,Transplant ,infectious diseases ,Kidney ,All institutes and research themes of the Radboud University Medical Center ,COVID‐19 ,Renal Dialysis ,Risk Factors ,risk factors ,Humans ,Eracoda ,Aged ,Sex Characteristics ,Multidisciplinary ,Dialysis patients ,Kidney Transplantation/adverse effects ,COVID-19 ,Middle Aged ,Kidney Transplantation ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,Nephrology ,3121 General medicine, internal medicine and other clinical medicine ,mortality risk ,Immunosuppressive Agents/therapeutic use ,Female ,Immunosuppressive Agents - Abstract
In the general population with COVID-19, the male sex is an established risk factor for mortality, in part due to a more robust immune response to COVID-19 in women. Because patients on kidney function replacement therapy (KFRT) have an impaired immune response, especially kidney transplant recipients due to their use of immunosuppressants, we examined whether the male sex is still a risk factor for mortality among patients on KFRT with COVID-19. From the European Renal Association COVID-19 Database (ERACODA), we examined patients on KFRT with COVID-19 who presented between February 1st, 2020, and April 30th, 2021. 1204 kidney transplant recipients (male 62.0%, mean age 56.4 years) and 3206 dialysis patients (male 61.8%, mean age 67.7 years) were examined. Three-month mortality in kidney transplant recipients was 16.9% in males and 18.6% in females (p = 0.31) and in dialysis patients 27.1% in males and 21.9% in females (p = 0.001). The adjusted HR for the risk of 3-month mortality in males (vs females) was 0.89 (95% CI 65, 1.23, p = 0.49) in kidney transplant recipients and 1.33 (95% CI 1.13, 1.56, p = 0.001) in dialysis patients (pinteraction = 0.02). In a fully adjusted model, the aHR for the risk of 3-month mortality in kidney transplant recipients (vs. dialysis patients) was 1.39 (95% CI 1.02, 1.89, p = 0.04) in males and 2.04 (95% CI 1.40, 2.97, p interaction = 0.02). In patients on KFRT with COVID-19, the male sex is not a risk factor for mortality among kidney transplant recipients but remains a risk factor among dialysis patients. The use of immunosuppressants in kidney transplant recipients, among other factors, may have narrowed the difference in the immune response to COVID-19 between men and women, and therefore reduced the sex difference in COVID-19 mortality risk.
- Published
- 2022
26. THSD7A-positive membranous nephropathy after kidney transplantation: A case report
- Author
-
Solà-Porta, Eulàlia, primary, Buxeda, Anna, additional, Lop, Joan, additional, Naranjo-Hans, Dolores, additional, Gimeno, Javier, additional, Lloveras-Rubio, Belén, additional, Pérez-Sáez, María José, additional, Redondo-Pachón, Dolores, additional, and Crespo, Marta, additional
- Published
- 2022
- Full Text
- View/download PDF
27. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19
- Author
-
Duivenvoorden, Raphaël, Vart, Priya, Noordzij, Marlies, Soares Dos Santos, Augusto C., Zulkarnaev, Alex B., Franssen, Casper F. M., Kuypers, Dirk, Demir, Erol, Rahimzadeh, Hormat, Kerschbaum, Julia, Jager, Kitty J., Turkmen, Kultigin, Hemmelder, Marc H., Schouten, Marcel, Rodríguez-Ferrero, María Luisa, Crespo, Marta, Gansevoort, Ron T., Hilbrands, Luuk B., van der Net, Jeroen B., Essig, Marie, du Buf-Vereijken, Peggy W. G., van Ginneken, Betty, Maas, Nanda, Vogt, Liffert, van Jaarsveld, Brigit C., Bemelman, Frederike J., Klingenberg-Salahova, Farah, Heenan-Vos, Frederiek, Vervloet, Marc G., Nurmohamed, Azam, Abramowicz, Daniel, Verhofstede, Sabine, Maoujoud, Omar, Malfait, Thomas, Fialova, Jana, Melilli, Edoardo, Favà, Alexandre, Cruzado, Josep M., Montero Perez, Nuria, Lips, Joy, Krepel, Harmen, Adilovic, Harun, Hengst, Maaike, Konings, Constantijn, Rydzewski, Andrzej, Braconnier, Philippe, Weis, Daniel, Gellert, Ryszard, Oliveira, João, Alferes, Daniela G., Radulescu, Daniela, Zakharova, Elena V., Ambuehl, Patrice Max, Guidotti, Rebecca, Walker, Andrea, Lepeytre, Fanny, Rabaté, Clémentine, Rostoker, Guy, Marques, Sofia, Azasevac, Tijana, Strazmester Majstorovic, Gordana, Katicic, Dajana, ten Dam, Marc, Krüger, Thilo, Brzosko, Szymon, Liakopoulos, Vassilios, Zanen, Adriaan L., Logtenberg, Susan J. J., Fricke, Lutz, Kuryata, Olexandr, Slebe, Jeroen J. P., Abd Elhafeez, Samar, Kemlin, Delphine, van de Wetering, Jacqueline, Reinders, Marlies E. J., Hesselink, Dennis A., Kal-van Gestel, J., Eiselt, Jaromir, Kielberger, Lukas, el-Wakil, Hala S., Verhoeven, Martine, Logan, Ian, Canal, Cristina, Facundo, Carme, Ramos, Ana M., Debska-Slizien, Alicja, Veldhuizen, Nicoline M. H., Tigka, Eirini, Polyzou Konsta, Maria Anna, Panagoutsos, Stylianos, Mallamaci, Francesca, Postorino, Adele, Cambareri, Francesco, Matceac, Irina, Nistor, Ionut, Covic, Adrian, Groeneveld, J. H. M., Jousma, Jolanda, van Buren, Marjolijn, Diekmann, Fritz, Oppenheimer, Federico, Blasco, Miquel, Assis Pereira, Tiago, Arias-Cabrales, Carlos, Llinàs-Mallol, Laura, Buxeda, Anna, Tàrrega, Carla Burballa, Redondo-Pachon, Dolores, Jimenez, Maria Dolores Arenas, Mendoza-Valderrey, Alberto, Martins, Ana Cristina, Mateus, Catarina, Alvila, Goncalo, Laranjinha, Ivo, Hofstra, Julia M., Siezenga, Machiel A., Franco, Antonio, Arroyo, David, Castellano, Sandra, Balda Manzanos, Sagrario, Sosa Barrios, R. Haridian, Lemahieu, Wim, Bartelet, Karlijn, Burak Dirim, Ahmet, Sukru Sever, Mehmet, Turkmen, Aydin, Şafak, Seda, Hollander, Daan A. M. J., Büttner, Stefan, de Vries, Aiko P. J., Meziyerh, Soufian, van der Helm, Danny, Mallat, Marko, Bouwsma, Hanneke, Sridharan, Sivakumar, Petruliene, Kristina, Maloney, Sharon-Rose, Verberk, Iris, van der Sande, Frank M., Christiaans, Maarten H. L., Mohan Kumar, N., di Luca, Marina, Tuǧlular, Serhan Z., Kramer, Andrea, Beerenhout, Charles, Luik, Peter T., Tiefenthaler, Martin, Watschinger, Bruno, Adema, Aaltje Y., Stepanov, Vadim A., Gandolfini, Ilaria, Maggiore, Umberto, Fliedner, Anselm, Åsberg, Anders, Mjoen, Geir, Miyasato, Hitoshi, de Fijter, Carola W. H., Mongera, Nicola, Pini, Stefano, de Biase, Consuelo, Kerckhoffs, Angele, van de Logt, Anne Els, Maas, Rutger, Lebedeva, Olga, Lopez, Veronica, Reichert, Louis J. M., Verhave, Jacobien, Titov, Denis, Parshina, Ekaterina V., Zanoli, Luca, Marcantoni, Carmelita, van Kempen, Gijs, van Gils-Verrij, Liesbeth E. A., Harty, John C., Meurs, Marleen, Myslak, Marek, Battaglia, Yuri, Lentini, Paolo, den Deurwaarder, Edwin, Stendahl, Maria, Rychlik, Ivan, Cabezas-Reina, Carlos J., Maria Roca, Ana, Nauta, Ferdau, Sahin, İdris, Goffin, Eric, Kanaan, Nada, Labriola, Laura, Devresse, Arnaud, Diaz-Mareque, Anabel, Coca, Armando, de Arriba, Gabriel, Meijers, Björn K. I., Naesens, Maarten, Desschans, Bruno, Tonnerlier, Annelies, Wissing, Karl M., Dedinska, Ivana, Pessolano, Giuseppina, Malik, Shafi, Dounousi, Evangelia, Papachristou, Evangelos, Berger, Stefan P., Meijer, Esther, Sanders, Jan Stephan F., Özyilmaz, Akin, Buturović Ponikvar, Jadranka, Marn Pernat, Andreja, Kovac, Damjan, Arnol, Miha, Ekart, Robert, Abrahams, Alferso C., Molenaar, Femke M., van Zuilen, Arjan D., Meijvis, Sabine C. A., Dolmans, Helma, Tantisattamo, Ekamol, Esposito, Pasquale, Krzesinski, Jean-Marie, Barahira, Jean Damacène, Gallieni, Maurizio, Martin-Moreno, Paloma Leticia, Guglielmetti, Gabriele, Guzzo, Gabriella, Toapanta, Nestor, Jose Soler, Maria, Luik, Antinus J., van Kuijk, Willi H. M., Stikkelbroeck, Lonneke W. H., Hermans, Marc M. H., Rimsevicius, Laurynas, Righetti, Marco, Islam, Mahmud, Heitink-ter Braak, Nicole, Groningen Kidney Center (GKC), Cardiovascular Centre (CVC), UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie, Medical Informatics, ACS - Pulmonary hypertension & thrombosis, APH - Aging & Later Life, APH - Quality of Care, APH - Global Health, Nephrology, ACS - Diabetes & metabolism, Internal Medicine, Interne Geneeskunde, RS: Carim - V02 Hypertension and target organ damage, and Clinical sciences
- Subjects
kidney transplant ,Adult ,Kidney Disease ,Outcome Assessment ,Renal and urogenital ,infectious diseases ,Medical and Health Sciences ,clinical ,DISEASE ,All institutes and research themes of the Radboud University Medical Center ,Rare Diseases ,SDG 3 - Good Health and Well-being ,7.1 Individual care needs ,Clinical Research ,Outcome Assessment, Health Care ,Humans ,Retrospective Studies ,Transplantation ,SARS-CoV-2 ,MORTALITY ,Rehabilitation ,COVID-19 ,mental health outcomes ,survive ,Organ Transplantation ,Original Clinical Science—General ,Middle Aged ,SOLID-ORGAN TRANSPLANT ,Kidney Transplantation ,Transplant Recipients ,DIALYSIS PATIENTS ,Health Care ,functional ,Intensive Care Units ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,Good Health and Well Being ,Nephrology ,ERACODA ,ERACODA Collaborators ,Surgery ,Management of diseases and conditions ,Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] - Abstract
BACKGROUND: Kidney transplant patients are at high risk for coronavirus disease 2019 (COVID-19)-related mortality. However, limited data are available on longer-term clinical, functional, and mental health outcomes in patients who survive COVID-19.METHODS: We analyzed data from adult kidney transplant patients in the European Renal Association COVID-19 Database who presented with COVID-19 between February 1, 2020, and January 31, 2021.RESULTS: We included 912 patients with a mean age of 56.7 (±13.7) y. 26.4% were not hospitalized, 57.5% were hospitalized without need for intensive care unit (ICU) admission, and 16.1% were hospitalized and admitted to the ICU. At 3 mo follow-up survival was 82.3% overall, and 98.8%, 84.2%, and 49.0%, respectively, in each group. At 3 mo follow-up biopsy-proven acute rejection, need for renal replacement therapy, and graft failure occurred in the overall group in 0.8%, 2.6%, and 1.8% respectively, and in 2.1%, 10.6%, and 10.6% of ICU-admitted patients, respectively. Of the surviving patients, 83.3% and 94.4% reached their pre-COVID-19 physician-reported functional and mental health status, respectively, within 3 mo. Of patients who had not yet reached their prior functional and mental health status, their treating physicians expected that 79.6% and 80.0%, respectively, still would do so within the coming year. ICU admission was independently associated with a low likelihood to reach prior functional and mental health status.CONCLUSIONS: In kidney transplant recipients alive at 3-mo follow-up, clinical, physician-reported functional, and mental health recovery was good for both nonhospitalized and hospitalized patients. Recovery was, however, less favorable for patients who had been admitted to the ICU.
- Published
- 2022
28. Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study
- Author
-
Bolufer, Mónica, primary, García-Carro, Clara, additional, Blasco, Miquel, additional, Quintana, Luis F., additional, Shabaka, Amir, additional, Rabasco, Cristina, additional, Draibe, Juliana, additional, Merino, Ana, additional, Melero, María Rosa, additional, Alonso, Fabiola, additional, Buxeda, Anna, additional, Batalha, Paula, additional, Visús, Maria Teresa, additional, and Soler, Maria José, additional
- Published
- 2022
- Full Text
- View/download PDF
29. MO991: Covid-19 Infection After Kidney Transplantation in Spain: Comparable Impact Throughout Six Epidemic Waves
- Author
-
Llinàs-Mallol, Laura, primary, Burballa, Carla, additional, Redondo Pachon, Dolores, additional, Solà, Eulàlia, additional, Arias-Cabrales, Carlos, additional, Buxeda, Anna, additional, Martinez Saez, Aida, additional, Bach, Anna, additional, Pascual, Julio, additional, José Pérez-Saéz, María, additional, and Crespo, Marta, additional
- Published
- 2022
- Full Text
- View/download PDF
30. MO052: New Trend in the Diagnosis of Kidney Disease in Cancer Patients: A Multicenter Study
- Author
-
Bolufer, Mónica, primary, Garcia Carro, Clara, additional, Blasco, Miquel, additional, Fernando Quintana Porras, Luis, additional, Shabaka, Amir, additional, Rabasco, Cristina, additional, Draibe, Juliana, additional, Merino Ribas, Ana, additional, Rosa Melero Martin, Maria, additional, Alonso Garcia, Fabiola, additional, Buxeda, Anna, additional, Batalha, Paula, additional, Teresa Visus, Maria, additional, and José Soler Romeo, Maria, additional
- Published
- 2022
- Full Text
- View/download PDF
31. MO984: Increased Mortality After Kidney Transplantation in Mildly Frail Recipients: Need for Pretransplant Intervention
- Author
-
Pascual, Julio, primary, Arias Cabrales, Carlos, additional, Redondo Pachon, Dolores, additional, Burballa, Carla, additional, Buxeda, Anna, additional, Bach, Anna, additional, Faura, Anna, additional, Marco, Esther, additional, Rodriguez, Leocadio, additional, Crespo, Marta, additional, and José Pérez-Saéz, María, additional
- Published
- 2022
- Full Text
- View/download PDF
32. FC 109: Microvascular Inflammation in Kidney Transplant Biopsies in the Absence of HLA-DSA Displays Intense Cytotoxic T-Cell and NK Cell but not Plasma Cell Infiltration
- Author
-
Buxeda, Anna, primary, Llinàs-Mallol, Laura, additional, Gimeno, Javier, additional, Redondo Pachon, Dolores, additional, Arias-Cabrales, Carlos, additional, Burballa, Carla, additional, Puche, Adrián, additional, José Pérez-Saéz, María, additional, Pascual, Julio, additional, and Crespo, Marta, additional
- Published
- 2022
- Full Text
- View/download PDF
33. Corrigendum to “Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration” [American Journal of Transplantation 23 (2023) 464–474]
- Author
-
Buxeda, Anna, Llinàs-Mallol, Laura, Gimeno, Javier, Redondo-Pachón, Dolores, Arias-Cabrales, Carlos, Burballa, Carla, Puche, Adrián, López-Botet, Miguel, Yélamos, José, Vilches, Carlos, Naesens, Maarten, Pérez-Sáez, María José, Pascual, Julio, and Crespo, Marta
- Published
- 2024
- Full Text
- View/download PDF
34. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
- Author
-
Caravaca-Fontán, Fernando, Polanco, Natalia, Villacorta, Blanca, Buxeda, Anna, Coca, Armando, Ávila, Ana, Martínez-Gallardo, Rocío, Galeano, Cristina, Valero, Rosalía, Ramos, Natalia, Allende, Natalia, Cruzado-Vega, Leónidas, Pérez-Sáez, María José, Sevillano, Ángel, González, Esther, Hernández, Ana, Rodrigo, Emilio, Fernández-Ruiz, Mario, Aguado, José María, and Valdivia, Miguel Ángel Pérez
- Subjects
KIDNEY transplantation ,IMMUNE complexes ,GLOMERULONEPHRITIS ,KIDNEY diseases ,DISEASE remission ,NEPHRITIS ,KIDNEY failure - Abstract
Introduction Membranoproliferative glomerulonephritis (MPGN) represents a histologic pattern of glomerular injury that may be due to several aetiologies. Few studies have comprehensively analysed the recurrence of MPGN according to the current classification system. Methods We collected a multicentre, retrospective cohort of 220 kidney graft recipients with biopsy-proven native kidney disease due to MPGN between 1981 and 2021 in 11 hospitals. Demographic, clinical and histologic parameters of prognostic interest were collected. The main outcomes were time to kidney failure, time to recurrence of MPGN and disease remission after recurrence. Results The study group included 34 complement-mediated and 186 immune complex–mediated MPGN. A total of 81 patients (37%) reached kidney failure in a median follow-up of 79 months. The main predictors of this event were the development of rejection episodes and disease recurrence. In all, 54 patients (25%) had a disease recurrence in a median of 16 months after kidney transplantation. The incidence of recurrence was higher in patients with dysproteinaemia (67%) and complement-mediated MPGN (62%). In the multivariable model, complement-mediated MPGN emerged as a predictor of recurrence. A total of 33 patients reached kidney failure after recurrence. The main determinants of no remission were early time to recurrence (<15 months), estimated glomerular filtration rate <30 mL/min/1.73 m
2 and serum albumin <3.5 g/dL at the time of recurrence. Conclusions One-fourth of the patients with native kidney disease due to MPGN developed clinical recurrence in the allograft, especially in cases with complement-mediated disease or in those associated with dysproteinaemia. The kidney outcomes of disease recurrence with currently available therapies are heterogeneous and thus more effective and individualized therapies are needed. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
35. Outcomes of Frail Patients While Waiting for Kidney Transplantation: Differences between Physical Frailty Phenotype and FRAIL Scale
- Author
-
Pérez-Sáez, María José, primary, Redondo-Pachón, Dolores, additional, Arias-Cabrales, Carlos E., additional, Faura, Anna, additional, Bach, Anna, additional, Buxeda, Anna, additional, Burballa, Carla, additional, Junyent, Ernestina, additional, Crespo, Marta, additional, Marco, Ester, additional, Rodríguez-Mañas, Leocadio, additional, and Pascual, Julio, additional
- Published
- 2022
- Full Text
- View/download PDF
36. Early Hypertransaminasemia after Kidney Transplantation: Significance and Evolution According to Donor Type
- Author
-
Solà-Porta, Eulàlia, primary, Redondo-Pachón, Dolores, additional, Arias-Cabrales, Carlos, additional, Navazo, Diego, additional, Buxeda, Anna, additional, Burballa, Carla, additional, Crespo, Marta, additional, García-Retortillo, Montserrat, additional, Pascual, Julio, additional, and Pérez-Sáez, María José, additional
- Published
- 2021
- Full Text
- View/download PDF
37. Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution
- Author
-
Montero, Nuria, primary, Toapanta, Néstor, additional, Pallarès, Natàlia, additional, Crespo, Marta, additional, Diekmann, Fritz, additional, Guirado, Lluis, additional, Esteban, Rafael, additional, Codina, Sergi, additional, Melilli, Edoardo, additional, Buxeda, Anna, additional, Velis, Gonzalo, additional, Torres, Irina B., additional, Revuelta, Ignacio, additional, Molina Andujar, Alicia, additional, Facundo, Carme, additional, Bardají, Beatriz, additional, Riera, Lluís, additional, Fiol, Maria, additional, Cruzado, Josep M., additional, Comas, Jordi, additional, Giral, Magali, additional, Naesens, Maarten, additional, Åsberg, Anders, additional, Moreso, Francesc, additional, and Bestard, Oriol, additional
- Published
- 2021
- Full Text
- View/download PDF
38. Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine
- Author
-
Arias-Cabrales, Carlos, Folgueiras, Montserrat, Faura, Anna, Eguia, Jorge, Padilla, Eduardo, Hurtado, Sara, Ribera, Laura, Echeverria-Esnal, Daniel, Pérez-Sáez, María José, Redondo-Pachón, Dolores, Burballa, Carla, Buxeda, Anna, Llinàs-Mallol, Laura, Cao, Higini, Barbosa, Francesc, Rovira, Xavier, Cima, Florencia, Pascual, Julio, and Crespo, Marta
- Published
- 2023
- Full Text
- View/download PDF
39. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody–associated vasculitis.
- Author
-
Rodríguez, Eva, Latzke, Belén, Sierra, Milagros, Romera, Ana María, Siedel, Diego, Agraz, Irene, Soler, María José, García-Carro, Clara, Draibe, Juliana, Prada, Francisco José de la, Villacorta, Javier, Buxeda, Anna, Sierra-Ochoa, Adriana, Lozano, Inés, Durán, Xavier, Barrios, Clara, and Pascual, Julio
- Subjects
LUPUS nephritis ,RECEIVER operating characteristic curves ,PROTEINASES ,IMMUNOGLOBULINS ,NEPHRITIS ,CHEMILUMINESCENCE immunoassay - Abstract
Background The value of myeloperoxidase (MPO) and proteinase 3 (PR3) antibody titres in the assessment of renal disease activity and flare prediction in patients with anti-neutrophil cytoplasmic antibody–associated vasculitis (AAV) is not well known. Methods We performed a retrospective study including 113 AVV patients with renal biopsy–proven pauci-immune necrotizing glomerulonephritis from seven Spanish hospitals. The main inclusion criteria were assessment of MPO antibodies using multiplex flow immunoassay and PR3 antibody measurements using immunoassay chemiluminescence with an identical range of values for all participating centres. Results Serum MPO antibodies 3 ± 1.2 months before relapse were higher in patients who relapsed [19.2 ± 12.2 versus 3.2 ± 5.1 antibody index (AI); P < 0.001]. The discrimination value of MPO antibodies 3 months before renal relapse had an area under the receiver operating characteristics curve (AUC) of 0.82 [95% confidence interval (CI) 0.73–0.92; P < 0.001]. ΔMPO antibodies (change in antibodies titration 6 months before relapse) were higher in patients who relapsed (8.3 ± 12 versus 0.9 ± 3.1 AI; P = 0.001). The discrimination value of ΔMPO had an AUC of 0.76 (95% CI 0.63–0.88; P < 0.001). The positive predictive value of renal relapse in PR3 patients is 100% and the negative predictive value of renal relapse in patients with PR3-positive titres is 57.1%. Serum PR3 antibodies were higher in patients who relapsed 2.8 ± 1.4 months before relapse (58.6 ± 24.6 versus 2.0 ± 0.6 AI; P < 0.001). Conclusions MPO level monitoring using multiplex flow immunoassay and PR3 measurements using immunoassay chemiluminescence are useful and sensitive tools for the prediction of renal relapse in the follow-up of AAV patients with renal disease and relevant surrogate markers of renal disease activity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Corrigendum to “Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration” [American Journal of Transplantation23 (2023) 464–474]
- Author
-
Buxeda, Anna, Llinàs-Mallol, Laura, Gimeno, Javier, Redondo-Pachón, Dolores, Arias-Cabrales, Carlos, Burballa, Carla, Puche, Adrián, López-Botet, Miguel, Yélamos, José, Vilches, Carlos, Naesens, Maarten, Pérez-Sáez, María José, Pascual, Julio, and Crespo, Marta
- Published
- 2024
- Full Text
- View/download PDF
41. Evolución de las causas de pérdida del injerto en trasplante renal durante 40 años (1979-2019)
- Author
-
Redondo-Pachón, Dolores, Calatayud, Emma, Buxeda, Anna, Pérez-Sáez, María José, Arias-Cabrales, Carlos, Gimeno, Javier, Burballa, Carla, Mir, Marisa, Llinàs-Mallol, Laura, Outon, Sara, Pascual, Julio, and Crespo, Marta
- Abstract
La mejoría en la supervivencia del receptor y del injerto renal sufre un proceso de deceleración. La tasa de pérdida del injerto a medio y largo plazo permanece estable desde hace 25 años. Es fundamental conocer las causas de pérdida del injerto y los factores relacionados, así como identificar si se han producido cambios en las causas de pérdida del injerto en los últimos años.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.